Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Parish

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
Future Microbiology|February 18, 2015
The future for early-stage tuberculosis drug discoveryEdison S Zuniga, Julie Early, Tanya Parish
Tuberculosis (Edinburgh, Scotland)|April 27, 2005
HemZ is essential for heme biosynthesis in Mycobacterium tuberculosisTanya Parish, Merrill Schaeffer, Gretta Roberts, et al.
Applied and Environmental Microbiology|June 4, 2005
Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatisPaul Carroll, D G Niranjala Muttucumaru, Tanya Parish
Applied and Environmental Microbiology|June 7, 2011
Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approachPaul Carroll, Marie-Claire Faray-Kele, Tanya Parish
Biorxiv : the Preprint Server for Biology|March 3, 2023
Inoculum-dependent bactericidal activity of a <i>Mycobacterium tuberculosis</i> MmpL3 inhibitorBryan Berube, Aditi Deshpande, Amala Bhagwat, et al.
European Journal of Medicinal Chemistry|August 21, 2021
Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoB<sub>S522L</sub> strain and display a different binding mode at the RNAP β-subunit site compared to rifampicinMire Zloh, Megha Gupta, Tanya Parish, et al.
FEMS Microbiology Letters|April 16, 2003
Control of the acetamidase gene of Mycobacterium smegmatis by multiple regulatorsGretta Roberts, D G Niranjala Muttucumaru, Tanya Parish
Microbiology (Reading, England)|June 19, 2023
Inoculum-dependent bactericidal activity of a <i>Mycobacterium tuberculosis</i> MmpL3 inhibitorBryan Berube, Aditi Deshpande, Amala Bhagwat, et al.
Access Microbiology|September 25, 2020
Cell wall inhibitors increase the accumulation of rifampicin in <i>Mycobacterium tuberculosis</i>Matthew B McNeil, Somsundaram Chettiar, Divya Awasthi, et al.
Future Microbiology|May 7, 2013
Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targetsDavid M Roberts, Yoann Personne, Juliane Ollinger, et al.
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Future Microbiology|February 18, 2015
The future for early-stage tuberculosis drug discoveryEdison S Zuniga, Julie Early, Tanya Parish
Tuberculosis (Edinburgh, Scotland)|April 27, 2005
HemZ is essential for heme biosynthesis in Mycobacterium tuberculosisTanya Parish, Merrill Schaeffer, Gretta Roberts, et al.
Applied and Environmental Microbiology|June 4, 2005
Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatisPaul Carroll, D G Niranjala Muttucumaru, Tanya Parish
Applied and Environmental Microbiology|June 7, 2011
Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approachPaul Carroll, Marie-Claire Faray-Kele, Tanya Parish
Biorxiv : the Preprint Server for Biology|March 3, 2023
Inoculum-dependent bactericidal activity of a <i>Mycobacterium tuberculosis</i> MmpL3 inhibitorBryan Berube, Aditi Deshpande, Amala Bhagwat, et al.
European Journal of Medicinal Chemistry|August 21, 2021
Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoB<sub>S522L</sub> strain and display a different binding mode at the RNAP β-subunit site compared to rifampicinMire Zloh, Megha Gupta, Tanya Parish, et al.
FEMS Microbiology Letters|April 16, 2003
Control of the acetamidase gene of Mycobacterium smegmatis by multiple regulatorsGretta Roberts, D G Niranjala Muttucumaru, Tanya Parish
Microbiology (Reading, England)|June 19, 2023
Inoculum-dependent bactericidal activity of a <i>Mycobacterium tuberculosis</i> MmpL3 inhibitorBryan Berube, Aditi Deshpande, Amala Bhagwat, et al.
Access Microbiology|September 25, 2020
Cell wall inhibitors increase the accumulation of rifampicin in <i>Mycobacterium tuberculosis</i>Matthew B McNeil, Somsundaram Chettiar, Divya Awasthi, et al.
Future Microbiology|May 7, 2013
Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targetsDavid M Roberts, Yoann Personne, Juliane Ollinger, et al.
Pageof 21